Customized research for ABUS vs. FTSV!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ABUS vs. FTSV.


↗ Join Our Free Email Newsletter.




Arbutus Biopharma Corporation vs. Forty Seven Inc. Cl A

Industry Match! Industry of Both ABUS and FTSV:

Health Care/Life Sciences

ABUS
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 87.771M


P/E: N/A

P/S: 14.75

Q P/B: 0.53

Y Rev: 5.95M

Q Rev: 653,000

Beta: 2.02

ABUS Share Stats

Outstanding Shares

56.85M

Float Shares

36.33M

Percent of Float Short

3.60%

ABUS Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

ABUS Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ABUS in Pulse Portal

Stream of Posts

ABUS Symbol Page

Share ABUS Insights

Express Sentiment

'Buy' or 'Sell' ABUS

ABUS Profile

CEO

Dr. Frank Torti

Exchange

Nasdaq

Employees

80.00

About

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.

ABUS Financials

Annual Financials

Income Statement

Revenue

5.95M

Net Income

(57.06M)

Cash Flow Statement

Change in Cash / Investments

(17.35M)

Balance Sheet

Cash / Investments

124.62M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

129.23M

Total Current Liabilities

11.24M

Total Assets

227.91M

Total Liabilities

27.67M

Stockholder Equity

200.23M

Quarterly Financials

Income Statement

Q Revenue

653,000

Q Net Income

(23.32M)

Cash Flow Statement

Q Change in Cash / Investments

(5.23M)

Balance Sheet

Q Cash / Investments

95.28M

Q Short Term Debt

376,000

Q Long Term Debt

None

Q Total Current Assets

99.58M

Q Total Current Liabilities

8.8M

Q Total Assets

192.57M

Q Total Liabilities

28.1M

Q Stockholder Equity

164.47M

ABUS Charts

10-Year Chart

ABUS 10-Year Chart

5-Year Chart

ABUS 5-Year Chart

1-Year Chart

ABUS 1-Year Chart

6-Month Chart

ABUS 6-Month Chart

3-Month Chart

ABUS 3-Month Chart

1-Month Chart

ABUS 1-Month Chart

1-Day Chart

ABUS 1-Day Chart

FTSV
Data Last Updated: 2 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 270.177M


P/E: N/A

P/S: N/A

Q P/B: 2.95

Y Rev: -

Q Rev: -

Beta: N/A

FTSV Share Stats

Outstanding Shares

40.73M

Float Shares

16.71M

Percent of Float Short

11.13%

FTSV Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

FTSV Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FTSV in Pulse Portal

Stream of Posts

FTSV Symbol Page

Share FTSV Insights

Express Sentiment

'Buy' or 'Sell' FTSV

FTSV Profile

CEO

Dr. Mark Chao

Exchange

Nasdaq

Employees

57.00

About

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving...

FTSV Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(70.37M)

Cash Flow Statement

Change in Cash / Investments

(13.58M)

Balance Sheet

Cash / Investments

139.02M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

145.86M

Total Current Liabilities

15.41M

Total Assets

149.44M

Total Liabilities

16.22M

Stockholder Equity

133.22M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(23.21M)

Cash Flow Statement

Q Change in Cash / Investments

2.31M

Balance Sheet

Q Cash / Investments

99.01M

Q Short Term Debt

1.4M

Q Long Term Debt

None

Q Total Current Assets

110.87M

Q Total Current Liabilities

22.36M

Q Total Assets

115.8M

Q Total Liabilities

24.32M

Q Stockholder Equity

91.48M

FTSV Charts

10-Year Chart

FTSV 10-Year Chart

5-Year Chart

FTSV 5-Year Chart

1-Year Chart

FTSV 1-Year Chart

6-Month Chart

FTSV 6-Month Chart

3-Month Chart

FTSV 3-Month Chart

1-Month Chart

FTSV 1-Month Chart

1-Day Chart

FTSV 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon